310 related articles for article (PubMed ID: 30327364)
1. Plasma Lipidomic Profiling and Risk of Type 2 Diabetes in the PREDIMED Trial.
Razquin C; Toledo E; Clish CB; Ruiz-Canela M; Dennis C; Corella D; Papandreou C; Ros E; Estruch R; Guasch-Ferré M; Gómez-Gracia E; Fitó M; Yu E; Lapetra J; Wang D; Romaguera D; Liang L; Alonso-Gómez A; Deik A; Bullo M; Serra-Majem L; Salas-Salvadó J; Hu FB; Martínez-González MA
Diabetes Care; 2018 Dec; 41(12):2617-2624. PubMed ID: 30327364
[TBL] [Abstract][Full Text] [Related]
2. Plasma lipidome patterns associated with cardiovascular risk in the PREDIMED trial: A case-cohort study.
Razquin C; Liang L; Toledo E; Clish CB; Ruiz-Canela M; Zheng Y; Wang DD; Corella D; Castaner O; Ros E; Aros F; Gomez-Gracia E; Fiol M; Santos-Lozano JM; Guasch-Ferre M; Serra-Majem L; Sala-Vila A; Buil-Cosiales P; Bullo M; Fito M; Portoles O; Estruch R; Salas-Salvado J; Hu FB; Martinez-Gonzalez MA
Int J Cardiol; 2018 Feb; 253():126-132. PubMed ID: 29306452
[TBL] [Abstract][Full Text] [Related]
3. Association of the odd-chain fatty acid content in lipid groups with type 2 diabetes risk: A targeted analysis of lipidomics data in the EPIC-Potsdam cohort.
Prada M; Wittenbecher C; Eichelmann F; Wernitz A; Drouin-Chartier JP; Schulze MB
Clin Nutr; 2021 Aug; 40(8):4988-4999. PubMed ID: 34364238
[TBL] [Abstract][Full Text] [Related]
4. Plasma Acylcarnitines and Risk of Type 2 Diabetes in a Mediterranean Population at High Cardiovascular Risk.
Guasch-Ferré M; Ruiz-Canela M; Li J; Zheng Y; Bulló M; Wang DD; Toledo E; Clish C; Corella D; Estruch R; Ros E; Fitó M; Arós F; Fiol M; Lapetra J; Serra-Majem L; Liang L; Papandreou C; Dennis C; Martínez-González MA; Hu FB; Salas-Salvadó J
J Clin Endocrinol Metab; 2019 May; 104(5):1508-1519. PubMed ID: 30423132
[TBL] [Abstract][Full Text] [Related]
5. Plasma metabolite profile of legume consumption and future risk of type 2 diabetes and cardiovascular disease.
Margara-Escudero HJ; Paz-Graniel I; García-Gavilán J; Ruiz-Canela M; Sun Q; Clish CB; Toledo E; Corella D; Estruch R; Ros E; Castañer O; Arós F; Fiol M; Guasch-Ferré M; Lapetra J; Razquin C; Dennis C; Deik A; Li J; Gómez-Gracia E; Babio N; Martínez-González MA; Hu FB; Salas-Salvadó J
Cardiovasc Diabetol; 2024 Jan; 23(1):38. PubMed ID: 38245716
[TBL] [Abstract][Full Text] [Related]
6. Plasma lipidomic profiles and cardiovascular events in a randomized intervention trial with the Mediterranean diet.
Toledo E; Wang DD; Ruiz-Canela M; Clish CB; Razquin C; Zheng Y; Guasch-Ferré M; Hruby A; Corella D; Gómez-Gracia E; Fiol M; Estruch R; Ros E; Lapetra J; Fito M; Aros F; Serra-Majem L; Liang L; Salas-Salvadó J; Hu FB; Martínez-González MA
Am J Clin Nutr; 2017 Oct; 106(4):973-983. PubMed ID: 28814398
[No Abstract] [Full Text] [Related]
7. Lysine pathway metabolites and the risk of type 2 diabetes and cardiovascular disease in the PREDIMED study: results from two case-cohort studies.
Razquin C; Ruiz-Canela M; Clish CB; Li J; Toledo E; Dennis C; Liang L; Salas-Huetos A; Pierce KA; Guasch-Ferré M; Corella D; Ros E; Estruch R; Gómez-Gracia E; Fitó M; Lapetra J; Romaguera D; Alonso-Gómez A; Serra-Majem L; Salas-Salvadó J; Hu FB; Martínez-González MA
Cardiovasc Diabetol; 2019 Nov; 18(1):151. PubMed ID: 31722714
[TBL] [Abstract][Full Text] [Related]
8. High plasma glutamate and low glutamine-to-glutamate ratio are associated with type 2 diabetes: Case-cohort study within the PREDIMED trial.
Liu X; Zheng Y; Guasch-Ferré M; Ruiz-Canela M; Toledo E; Clish C; Liang L; Razquin C; Corella D; Estruch R; Fito M; Gómez-Gracia E; Arós F; Ros E; Lapetra J; Fiol M; Serra-Majem L; Papandreou C; Martínez-González MA; Hu FB; Salas-Salvadó J
Nutr Metab Cardiovasc Dis; 2019 Oct; 29(10):1040-1049. PubMed ID: 31377179
[TBL] [Abstract][Full Text] [Related]
9. Walnut Consumption, Plasma Metabolomics, and Risk of Type 2 Diabetes and Cardiovascular Disease.
Guasch-Ferré M; Hernández-Alonso P; Drouin-Chartier JP; Ruiz-Canela M; Razquin C; Toledo E; Li J; Dennis C; Wittenbecher C; Corella D; Estruch R; Fitó M; Ros E; Babio N; Bhupathiraju SN; Clish CB; Liang L; Martínez-González MA; Hu FB; Salas-Salvadó J
J Nutr; 2021 Feb; 151(2):303-311. PubMed ID: 33382410
[TBL] [Abstract][Full Text] [Related]
10. Olive oil consumption, plasma metabolites, and risk of type 2 diabetes and cardiovascular disease.
García-Gavilán JF; Babio N; Toledo E; Semnani-Azad Z; Razquin C; Dennis C; Deik A; Corella D; Estruch R; Ros E; Fitó M; Arós F; Fiol M; Lapetra J; Lamuela-Raventos R; Clish C; Ruiz-Canela M; Martínez-González MÁ; Hu F; Salas-Salvadó J; Guasch-Ferré M
Cardiovasc Diabetol; 2023 Dec; 22(1):340. PubMed ID: 38093289
[TBL] [Abstract][Full Text] [Related]
11. Plasma metabolite profiles associated with the World Cancer Research Fund/American Institute for Cancer Research lifestyle score and future risk of cardiovascular disease and type 2 diabetes.
Rios S; García-Gavilán JF; Babio N; Paz-Graniel I; Ruiz-Canela M; Liang L; Clish CB; Toledo E; Corella D; Estruch R; Ros E; Fitó M; Arós F; Fiol M; Guasch-Ferré M; Santos-Lozano JM; Li J; Razquin C; Martínez-González MÁ; Hu FB; Salas-Salvadó J
Cardiovasc Diabetol; 2023 Sep; 22(1):252. PubMed ID: 37716984
[TBL] [Abstract][Full Text] [Related]
12. Plasma metabolites predict both insulin resistance and incident type 2 diabetes: a metabolomics approach within the Prevención con Dieta Mediterránea (PREDIMED) study.
Papandreou C; Bulló M; Ruiz-Canela M; Dennis C; Deik A; Wang D; Guasch-Ferré M; Yu E; Razquin C; Corella D; Estruch R; Ros E; Fitó M; Fiol M; Liang L; Hernández-Alonso P; Clish CB; Martínez-González MA; Hu FB; Salas-Salvadó J
Am J Clin Nutr; 2019 Mar; 109(3):626-634. PubMed ID: 30796776
[TBL] [Abstract][Full Text] [Related]
13. Changes in metabolomics profiles over ten years and subsequent risk of developing type 2 diabetes: Results from the Nurses' Health Study.
Wittenbecher C; Guasch-Ferré M; Haslam DE; Dennis C; Li J; Bhupathiraju SN; Lee CH; Qi Q; Liang L; Eliassen AH; Clish C; Sun Q; Hu FB
EBioMedicine; 2022 Jan; 75():103799. PubMed ID: 34979341
[TBL] [Abstract][Full Text] [Related]
14. Lipidomics profiling and risk of cardiovascular disease in the prospective population-based Bruneck study.
Stegemann C; Pechlaner R; Willeit P; Langley SR; Mangino M; Mayr U; Menni C; Moayyeri A; Santer P; Rungger G; Spector TD; Willeit J; Kiechl S; Mayr M
Circulation; 2014 May; 129(18):1821-31. PubMed ID: 24622385
[TBL] [Abstract][Full Text] [Related]
15. Lipidomic risk scores are independent of polygenic risk scores and can predict incidence of diabetes and cardiovascular disease in a large population cohort.
Lauber C; Gerl MJ; Klose C; Ottosson F; Melander O; Simons K
PLoS Biol; 2022 Mar; 20(3):e3001561. PubMed ID: 35239643
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal Plasma Lipidome and Risk of Type 2 Diabetes in a Large Sample of American Indians With Normal Fasting Glucose: The Strong Heart Family Study.
Miao G; Zhang Y; Huo Z; Zeng W; Zhu J; Umans JG; Wohlgemuth G; Pedrosa D; DeFelice B; Cole SA; Fretts AM; Lee ET; Howard BV; Fiehn O; Zhao J
Diabetes Care; 2021 Dec; 44(12):2664-2672. PubMed ID: 34702783
[TBL] [Abstract][Full Text] [Related]
17. Fasting plasma metabolites reflecting meat consumption and their associations with incident type 2 diabetes in two Swedish cohorts.
Noerman S; Johansson A; Shi L; Lehtonen M; Hanhineva K; Johansson I; Brunius C; Landberg R
Am J Clin Nutr; 2024 May; 119(5):1280-1292. PubMed ID: 38403167
[TBL] [Abstract][Full Text] [Related]
18. Plasma trimethylamine-N-oxide and related metabolites are associated with type 2 diabetes risk in the Prevención con Dieta Mediterránea (PREDIMED) trial.
Papandreou C; Bulló M; Zheng Y; Ruiz-Canela M; Yu E; Guasch-Ferré M; Toledo E; Clish C; Corella D; Estruch R; Ros E; Fitó M; Arós F; Fiol M; Lapetra J; Serra-Majem L; Gómez-Gracia E; Liang L; Fragkiadakis GA; Razquin C; Hu FB; Salas-Salvadó J
Am J Clin Nutr; 2018 Jul; 108(1):163-173. PubMed ID: 29982310
[TBL] [Abstract][Full Text] [Related]
19. Amino acid and lipid metabolism in post-gestational diabetes and progression to type 2 diabetes: A metabolic profiling study.
Lai M; Liu Y; Ronnett GV; Wu A; Cox BJ; Dai FF; Röst HL; Gunderson EP; Wheeler MB
PLoS Med; 2020 May; 17(5):e1003112. PubMed ID: 32433647
[TBL] [Abstract][Full Text] [Related]
20. Glycolysis/gluconeogenesis- and tricarboxylic acid cycle-related metabolites, Mediterranean diet, and type 2 diabetes.
Guasch-Ferré M; Santos JL; Martínez-González MA; Clish CB; Razquin C; Wang D; Liang L; Li J; Dennis C; Corella D; Muñoz-Bravo C; Romaguera D; Estruch R; Santos-Lozano JM; Castañer O; Alonso-Gómez A; Serra-Majem L; Ros E; Canudas S; Asensio EM; Fitó M; Pierce K; Martínez JA; Salas-Salvadó J; Toledo E; Hu FB; Ruiz-Canela M
Am J Clin Nutr; 2020 Apr; 111(4):835-844. PubMed ID: 32060497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
